x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

MedTech Global Insights

What"s next in the future of health? Welcome to MedTech Global Insights, the podcast dedicated to uncovering the most disruptive technologies and brilliant minds in the medical field. Whether you"re an industry professional, investor, or simply curious, subscribe for your dose of cutting-edge information and expert commentary.

science life sciences

All Episodes

02:05

USA Ophthalmic Tech: Pure Global on the FDA's...

MedTech Global Insights ·

2026/04/02

The U.S. FDA just reclassified a key category of optical diagnostic devices, a move that reshaped the competitive landscape for the entire ophthalmic tech industry last week. This is not just a minor regulatory update; it is a fundamental shift that could either fast-track your product to market or unleash a flood of new, agile competitors.In this episode, we dissect the FDA's final order and its strategic implications. We explore the critical pivot required for both established players and new

en

01:57

USA AI MedTech: Pure Global on the FDA's Hidden Data...

MedTech Global Insights ·

2026/04/01

The U.S. FDA has quietly dropped a bombshell on the AI medical device industry. A new draft guidance is set to redefine what "post-market surveillance" means for software, creating a complex and costly new reality for innovators. This episode dives into the critical shift from focusing on pre-market approval to the necessity of continuous, real-world performance monitoring.We explore the challenge through the lens of a startup with a newly cleared AI diagnostic tool. The celebration of market

en

02:16

Pure Global: Malaysia's MedTech Handshake, ASEAN's...

MedTech Global Insights ·

2026/03/31

In this episode of MedTech Global Insights, we unpack the most significant regulatory shift in Southeast Asia this year. The costly and time-consuming process of seeking individual device approvals in each country is being replaced by a powerful new trend: regulatory reliance. We dive into the new pilot program between Malaysia and Thailand that is creating an expedited pathway for market access.Imagine your company just spent two years and a significant budget getting your device approved in one

en

01:50

Pure Global: EU's MedTech Shortage & The New Supply...

MedTech Global Insights ·

2026/03/30

The European Union is taking decisive action to combat the critical shortage of medical devices, a problem that has plagued its healthcare systems since the rollout of MDR. This episode unpacks the European Commission's new proposal for a mandatory six-month notification period for discontinuing devices, and what it means for manufacturers. This isn't just another form to fill out. it's a fundamental shift in market responsibility that directly impacts product lifecycle management, supply chain

en

01:39

Pure Global: Germany's AI Device Sudden Compliance...

MedTech Global Insights ·

2026/03/29

This week, MedTech Global Insights explores the seismic shift in European regulations for AI-powered medical devices. A major EU Notified Body has dropped a new, mandatory cybersecurity guidance document, sending shockwaves through the industry by demanding retroactive compliance. We unpack what this means for manufacturers, from agile startups to global giants. We explore the stringent new requirements for a Software Bill of Materials (SBOM) and penetration testing, and the immediate compliance

en

01:59

USA's QMSR Shockwave: Pure Global on Surviving FDA's...

MedTech Global Insights ·

2026/03/28

The FDA has officially replaced the long-standing QSIT inspection model with a new approach under the Quality Management System Regulation (QMSR). This shift towards harmonization with ISO 13485 introduces a more holistic, risk-based auditing process, catching many MedTech manufacturers off guard and rendering their old preparation methods obsolete.This episode of MedTech Global Insights dives into what this change really means for your operations. We explore the critical differences between the

en

02:00

USA's FDA QMSR: Pure Global on Hidden Management...

MedTech Global Insights ·

2026/03/27

This week, MedTech Global Insights dives into the most significant U.S. regulatory shift of 2026: the FDA's new Quality Management System Regulation (QMSR). We uncover why this is far more than a simple alignment with international standards and exposes a new level of corporate liability.The episode reveals how FDA inspectors now have unprecedented access to high-level management review meetings. We explore a real-world case where a company's internal decision to 'monitor' a component risk, once a

en

01:48

Pure Global: USA MedTech Security & Why FDA's...

MedTech Global Insights ·

2026/03/26

The FDA's "honeymoon phase" for medical device cybersecurity is over. In this episode, we dissect the agency's heightened scrutiny on premarket submissions, moving beyond simple documentation to active verification. We explore the new, unwritten rules manufacturers must follow to avoid costly rejections.We look at the case of a company whose 510(k) submission was delayed for months. Despite providing a complete Software Bill of Materials (SBOM), they were rejected because a common open-source

en

02:15

USA 510(k) Cybersecurity: The 'Refuse to Accept' Trap...

MedTech Global Insights ·

2026/03/25

The FDA has drawn a new line in the sand for medical device market access, and non-compliance means immediate rejection. With the full implementation of Section 524B of the FD&C Act, robust cybersecurity documentation is no longer optional for any 510(k) submission of a connected "cyber device." This episode breaks down the critical new requirements that are already impacting market entry timelines.We explore the costly lesson of a European AI startup whose promising 510(k) submission was

en

01:50

U.S. AI Medical Devices: Cracking the New Code | Pure...

MedTech Global Insights ·

2026/03/24

This week on MedTech Global Insights, we dissect the groundbreaking new draft guidance from the U.S. FDA on AI and Machine Learning medical devices. This pivotal announcement introduces new requirements for adaptive algorithms, fundamentally changing the regulatory landscape for software as a medical device (SaMD) manufacturers worldwide. We explore what the new "Predetermined Change Control Plan" means for your technical dossier, validation strategies, and post-market surveillance. We break down

en

02:03

Pure Global: USA Robotic Surgery & FDA's Digital...

MedTech Global Insights ·

2026/03/23

This week, MedTech Global Insights explores a critical challenge for international manufacturers entering the U.S. market. We analyze the recent case of a leading Japanese robotics firm whose 510(k) submission for an innovative surgical system was rejected by the FDA. The cause was not clinical failure, but non-compliance with new digital submission standards and cybersecurity protocols.This episode breaks down the costly administrative and technical hurdles that can blindside even the most

en

02:00

US AI Diagnostics: Pure Global on FDA's Hidden Hurdles

MedTech Global Insights ·

2026/03/22

This week on MedTech Global Insights, we dive into a crucial, under-the-radar development from the U.S. FDA. We explore the recent clearance of an AI-powered triage tool for stroke detection and what this single approval reveals about the future of AI regulation in American healthcare. We move beyond the hype of algorithms and predictive accuracy to uncover the real challenges and expectations the FDA has for MedTech innovators. This episode is essential for anyone developing or seeking approval

en

01:59

Pure Global: EU MedTech's EUDAMED Deadline & Its...

MedTech Global Insights ·

2026/03/21

The clock is ticking on a major regulatory shift in the European Union. With the mandatory use of key EUDAMED modules fast approaching, the era of radical transparency for medical devices is here. This isn't just a compliance update; it's a fundamental change that exposes manufacturers to new levels of public and competitor scrutiny, where every piece of data is visible to the world.This episode of MedTech Global Insights unpacks the hidden risks and strategic challenges of the EUDAMED transition

en

01:47

USA's AI MedTech Shift: Pure Global on the FDA's...

MedTech Global Insights ·

2026/03/20

The U.S. FDA is changing the rules for AI in medical devices, promising faster innovation. This new framework allows for pre-approved algorithm updates, potentially slashing go-to-market timelines. But this speed comes with a cost.This episode of MedTech Global Insights unpacks the FDA's new guidance on Predetermined Change Control Plans (PCCPs). We explore how this shifts the regulatory burden from pre-market review to post-market vigilance and places immense new pressures on manufacturers to

en

01:56

Pure Global: EU IVDR Software's Silent Compliance Crisis

MedTech Global Insights ·

2026/03/19

The European IVDR continues to challenge MedTech manufacturers with inconsistent interpretations and sudden shifts in compliance requirements. This episode dives into a recent and critical development: the "silent reclassification" of certain diagnostic software, which is forcing companies to pull products from the market and re-evaluate their entire regulatory strategy.We explore a case study of a cancer risk-scoring software company that found its product non-compliant overnight due to a new

en

02:07

USA MedTech: Pure Global on the EU Post-Market Data Trap

MedTech Global Insights ·

2026/03/18

This week on MedTech Global Insights, we explore the hidden challenges of using European post-market data for FDA submissions. Following the FDA's recent guidance on Real-World Evidence (RWE), many non-U.S. manufacturers assumed their path to the American market would be easier. We reveal why that is often not the case.We break down the fundamental differences between the EU's requirements for Post-Market Surveillance and the FDA's expectations for RWE. This disconnect can lead to significant

en

01:53

EU's IVDR Surprise: Pure Global on the Legacy Device...

MedTech Global Insights ·

2026/03/17

This week, we dissect the European Commission's surprise March 2026 guidance document that is reshaping the IVDR transition for legacy devices. This last-minute clarification on clinical evidence requirements has invalidated the long-held assumption that a history of safe use is enough, creating an urgent documentation crisis for many established IVD products. We explore how this shift from passive to active data collection is catching even experienced manufacturers off guard. We break down the

en

01:43

China's Neuro-Device Shortcut: Pure Global's...

MedTech Global Insights ·

2026/03/16

China's NMPA just launched a new 'Green Channel' fast-track approval pathway for innovative neurology devices. This policy could slash market entry timelines for MedTech companies, but the requirements are stringent and differ significantly from FDA or EU standards. This episode breaks down what the new rules mean for global manufacturers. We dissect the NMPA's specific criteria for 'innovation,' discuss the potential pitfalls in the application process, and outline the strategic adjustments

en

01:54

Pure Global: UK's MedTech Shortcut & The Regulatory...

MedTech Global Insights ·

2026/03/15

The UK's MHRA is rolling out a new "regulatory reliance" pathway, promising to fast-track medical devices already approved in the US, EU, Canada, and other key markets. This could slash market entry times and costs, representing a major opportunity for MedTech manufacturers looking to expand their global footprint.However, this shortcut introduces new and complex strategic risks. What happens if your original FDA approval is modified or has new conditions attached? This episode explores how this

en

02:06

Pure Global: Germany's IVD Deadline & The SME...

MedTech Global Insights ·

2026/03/14

The European Union's In Vitro Diagnostic Regulation (IVDR) is creating a critical challenge for small and medium-sized MedTech companies. With deadlines looming, a severe shortage of Notified Bodies and an explosion in documentation requirements are putting immense pressure on innovators, forcing some to consider discontinuing established and vital diagnostic tools.This episode dives into the heart of the crisis, using Germany's vibrant SME sector as a case study. We explore the real-world

en

237 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter